Universal Vision Biotechnology Co., Ltd. (3218)
Market Open
15 Oct, 05:30 AM
TWSE TWSE Primary NT$
131. 50
-1.5
-1.1278%
NT$
12.88B Market Cap
- P/E Ratio
30% Div Yield
215,639 Volume
- Eps
NT$ 133
Previous Close Want to track 3218 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Universal Vision Biotechnology Co., Ltd. (3218) Statistics
Valuation metrics
Market Cap 12.88B
Enterprise value 11.77B
Trailing P/E (ttm) 9.84
Forward P/E -
PEG ratio 0.34
Price/Sales (ttm) 2.64
Price/Book (mrq) 2.91
Enterprise Value/Revenue 2.75
Enterprise Value/EBITDA 6.31
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 116.68K
Average volume (90 days) 209.14K
Price summary
52-Week low 122
52-Week high 161
Beta -
50-Day moving average 135.79
200-Day moving average 134.92
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 7.75
Trailing annual dividend yield 0.0583%
5-Year annual dividend yield -
Payout ratio 0.57
Dividend Date 22 Apr 2026
Ex-Dividend Date 26 Mar 2026
Last split factor 1,060:1,000
Last split Date 25 Aug 2023
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.27%
Operating margin 0.31%
Operational effectiveness
Return on assets 0.18%
Return on equity 0.3%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 50.45
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 13.48
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 12.14
Total debt (mrq) -
Total Debt/Equity (mrq) 0.39
Current ratio (mrq) 1.36%
Book value per share (mrq) 46.07
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
